JP2004523556A5 - - Google Patents

Download PDF

Info

Publication number
JP2004523556A5
JP2004523556A5 JP2002567294A JP2002567294A JP2004523556A5 JP 2004523556 A5 JP2004523556 A5 JP 2004523556A5 JP 2002567294 A JP2002567294 A JP 2002567294A JP 2002567294 A JP2002567294 A JP 2002567294A JP 2004523556 A5 JP2004523556 A5 JP 2004523556A5
Authority
JP
Japan
Prior art keywords
formula
group
composition
phenyl
schizophrenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002567294A
Other languages
English (en)
Japanese (ja)
Other versions
JP4276841B2 (ja
JP2004523556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from US10/081,761 external-priority patent/US6541513B2/en
Publication of JP2004523556A publication Critical patent/JP2004523556A/ja
Publication of JP2004523556A5 publication Critical patent/JP2004523556A5/ja
Application granted granted Critical
Publication of JP4276841B2 publication Critical patent/JP4276841B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002567294A 2001-02-27 2002-02-21 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物 Expired - Lifetime JP4276841B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (3)

Publication Number Publication Date
JP2004523556A JP2004523556A (ja) 2004-08-05
JP2004523556A5 true JP2004523556A5 (https=) 2005-12-22
JP4276841B2 JP4276841B2 (ja) 2009-06-10

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567294A Expired - Lifetime JP4276841B2 (ja) 2001-02-27 2002-02-21 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物

Country Status (25)

Country Link
US (1) US6541513B2 (https=)
EP (1) EP1401424B1 (https=)
JP (1) JP4276841B2 (https=)
KR (1) KR100886578B1 (https=)
CN (1) CN1262271C (https=)
AR (1) AR032876A1 (https=)
AT (1) ATE346597T1 (https=)
AU (1) AU2002242296B2 (https=)
BR (1) BR0207829A (https=)
CA (1) CA2439480C (https=)
CZ (1) CZ302412B6 (https=)
DE (1) DE60216457T2 (https=)
DK (1) DK1401424T3 (https=)
ES (1) ES2275844T3 (https=)
HU (1) HUP0303342A3 (https=)
IL (2) IL157588A0 (https=)
MX (1) MXPA03007722A (https=)
NO (1) NO20033801L (https=)
NZ (1) NZ527991A (https=)
PL (1) PL365021A1 (https=)
PT (1) PT1401424E (https=)
RS (1) RS51056B (https=)
RU (1) RU2302240C2 (https=)
TW (1) TWI251486B (https=)
WO (1) WO2002067927A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE267629T1 (de) * 2000-07-21 2004-06-15 Ortho Mcneil Pharm Inc Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
EP1383489B1 (en) * 2001-02-27 2007-05-09 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157594A0 (en) 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating anxiety disorders
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
ES2385087T3 (es) * 2005-07-26 2012-07-18 Sk Biopharmaceuticals Co., Ltd Procedimientos para tratar trastornos relacionados con sustancias
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189451A (zh) * 2013-03-12 2015-12-23 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CA2051697C (en) * 1989-06-09 1996-10-08 Malcolm Wilson Moon Heterocyclic amines having central nervous system activity
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Similar Documents

Publication Publication Date Title
JP2004523556A5 (https=)
ECSP088179A (es) Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos
JP2004527492A5 (https=)
IL189003A0 (en) Methods for treating substance-related disorders
JP2007505877A5 (https=)
JP2004525905A5 (https=)
RU2010148762A (ru) Тетразольные соединения для снижения концентрации мочевой кислоты
JP2011519865A5 (https=)
JP2004533415A5 (https=)
RU2003128984A (ru) Производные карбаматов для использования для лечения боли
IL157589A0 (en) Carbamate compounds for use in preventing or treating bipolar disorder
PT1408953E (pt) Compostos carbamato para utilizacao na prevencao ou tratamento do disturbio bipolar
CA2439480A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136391A (en) Carbamate compounds for use in preventing or treating anxiety disorders
CO6180505A2 (es) Metodos para el tratamiento de transtornos cocleares y vestibulares
WO2016077541A1 (en) Novel anti-infective compounds and methods using same
BR0112713A (pt) "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
EA200700871A1 (ru) Способы нейропротекции
JP2004517947A5 (https=)
MX2007010787A (es) Derivados de 1,2,4-triazinas, su preparacion y su aplicacion en terapia humana.
JP2006520807A5 (https=)
SE0400441D0 (sv) Novel Benzofurans and Indols
MY149385A (en) Methods for treating substance-related disorders
TH86240A (th) วิธีสำหรับการปกป้องระบบประสาท